<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Meylan F</submitter><funding>Intramural NIH HHS</funding><funding>Medical Research Council</funding><pagination>79-89</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2760084</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(1)</volume><pubmed_abstract>DR3 (TRAMP, LARD, WSL-1, TNFRSF25) is a death-domain-containing tumor necrosis factor (TNF)-family receptor primarily expressed on T cells. TL1A, the TNF-family ligand for DR3, can costimulate T cells, but the physiological function of TL1A-DR3 interactions in immune responses is not known. Using DR3-deficient mice, we identified DR3 as the receptor responsible for TL1A-induced T cell costimulation and dendritic cells as the likely source for TL1A during T cell activation. Despite its role in costimulation, DR3 was not required for in vivo T cell priming, for polarization into T helper 1 (Th1), Th2, or Th17 effector cell subtypes, or for effective control of infection with Toxoplasma gondii. Instead, DR3 expression was required on T cells for immunopathology, local T cell accumulation, and</pubmed_abstract><journal>Immunity</journal><pubmed_title>The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.</pubmed_title><pmcid>PMC2760084</pmcid><funding_grant_id>G0300180(65735)</funding_grant_id><funding_grant_id>G0500617(74644)</funding_grant_id><funding_grant_id>G0500617</funding_grant_id><funding_grant_id>Z01 AR041174-01</funding_grant_id><funding_grant_id>G0300180</funding_grant_id><pubmed_authors>Kinder M</pubmed_authors><pubmed_authors>Bundoc V</pubmed_authors><pubmed_authors>Shevach EM</pubmed_authors><pubmed_authors>Davidson TS</pubmed_authors><pubmed_authors>Kahle E</pubmed_authors><pubmed_authors>Meylan F</pubmed_authors><pubmed_authors>Jankovic D</pubmed_authors><pubmed_authors>Siegel RM</pubmed_authors><pubmed_authors>Wang EC</pubmed_authors><pubmed_authors>Acharya K</pubmed_authors><pubmed_authors>Hodges M</pubmed_authors><pubmed_authors>Keane-Myers A</pubmed_authors></additional><is_claimable>false</is_claimable><name>The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.</name><description>DR3 (TRAMP, LARD, WSL-1, TNFRSF25) is a death-domain-containing tumor necrosis factor (TNF)-family receptor primarily expressed on T cells. TL1A, the TNF-family ligand for DR3, can costimulate T cells, but the physiological function of TL1A-DR3 interactions in immune responses is not known. Using DR3-deficient mice, we identified DR3 as the receptor responsible for TL1A-induced T cell costimulation and dendritic cells as the likely source for TL1A during T cell activation. Despite its role in costimulation, DR3 was not required for in vivo T cell priming, for polarization into T helper 1 (Th1), Th2, or Th17 effector cell subtypes, or for effective control of infection with Toxoplasma gondii. Instead, DR3 expression was required on T cells for immunopathology, local T cell accumulation, and</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Jul</publication><modification>2025-04-03T23:19:02.408Z</modification><creation>2019-03-27T00:25:46Z</creation></dates><accession>S-EPMC2760084</accession><cross_references><pubmed>18571443</pubmed><doi>10.1016/j.immuni.2008.04.021</doi></cross_references></HashMap>